Nonaspirin NSAIDs and contralateral breast cancer risk
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.31949
Abstract: Laboratory studies suggest that inhibition of the cyclooxygenase (COX)‐2 enzymes inhibits breast cancer development. We aimed to evaluate whether postdiagnosis use of COX‐2 selective or other nonaspirin nonsteroidal anti‐inflammatory drugs (NSAIDs) reduce the risk of… read more here.
Keywords: use; breast cancer; nonaspirin nsaid; cancer ... See more keywords